RMD News: Here's Why you Should Add Nevro Stock to Your Portfolio Now - 24th Jan 2025, 2:58am

[annb0t]

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results, is expected to contribute further. However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist.

This Zacks Rank #2 (Buy) company’s shares have lost 49.7% in the past six months against the industry’s 3.5% growth. The S&P 5...

>>> Read more: Here's Why you Should Add Nevro Stock to Your Portfolio Now